Citation Impact

Citing Papers

2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
2007 StandoutScienceNobel
The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure
2004
A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity
2007
Epidemiology and causes of preterm birth
2008 Standout
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Genetic contributions to preterm birth: Implications from epidemiological and genetic association studies
2008
Acute kidney injury
2012 Standout
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications
2012 Standout
Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients
2011
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
HIF-Dependent Antitumorigenic Effect of Antioxidants In Vivo
2007 StandoutNobel
Pharmacogenetics of the human beta-adrenergic receptors
2006
Therapies for Hemorrhagic Transformation in Acute Ischemic Stroke
2017
N‐acetylcysteine – passe‐partout or much ado about nothing?
2005
Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients
2007
Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF
2016
The Human Obesity Gene Map: The 2005 Update
2006
GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling
2006 StandoutNobel
Effects of Low-Sodium Diet vs. High-Sodium Diet on Blood Pressure, Renin, Aldosterone, Catecholamines, Cholesterol, and Triglyceride (Cochrane Review)
2011
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
The genomics of preterm birth: from animal models to human studies
2013
Gastrointestinal motility and glycemic control in diabetes: the chicken and the egg revisited?
2006
Recent advances in drug action and therapeutics: Relevance of novel concepts in G‐protein‐coupled receptor and signal transduction pharmacology
2004
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Sympathetic hyperactivity in chronic kidney disease: Pathogenesis, clinical relevance, and treatment
2004
The use of high‐dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome
2006
Genetic variants in pre-eclampsia: a meta-analysis
2013
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Will tomorrow's medicines work for everyone?
2004
Polymorphisms of the β1-adrenergic receptor predict exercise capacity in heart failure
2002
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Role of Dietary Salt and Potassium Intake in Cardiovascular Health and Disease: A Review of the Evidence
2013
The Third Intracellular Loop and the Carboxyl Terminus of β2-Adrenergic Receptor Confer Spontaneous Activity of the Receptor
2003 StandoutNobel
Prophylaxis Strategies for Contrast-Induced Nephropathy
2006
Toward a Causal Model of Cardiovascular Responses to Stress and the Development of Cardiovascular Disease
2003
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Genetic variation associated with preterm birth: A HuGE review
2005
Prevention of cardiovascular events in end-stage renal disease: Results of a randomized trial of fosinopril and implications for future studies
2006
N-Acetylcysteine in the prevention of contrast-induced nephropathy: Publication bias perpetuated by meta-analyses
2007
Pharmacogenetics goes genomic
2003
Acetylcysteine in the Prevention of Contrast-Induced Nephropathy
2006
Constructive and unconstructive repetitive thought.
2008 Standout
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
2007 Standout
Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride
2011
The Human Obesity Gene Map: The 2003 Update
2004
Impact of Informing Overweight Individuals about the Role of Genetics in Obesity: An Online Experimental Study
2013 Standout
Insights into bombesin receptors and ligands: Highlighting recent advances
2015
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
A marker for Stevens–Johnson syndrome
2004 StandoutNature
Intravenous Fluids and Acute Kidney Injury
2017 Standout
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage
2015
Genetics of Food Intake Self-Regulation in Childhood: Literature Review and Research Opportunities
2013 Standout
Chronic Kidney Disease
2016 Standout
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
2006 Standout
The Human Obesity Gene Map: The 2004 Update
2005
Adipose Tissue as an Endocrine Organ
2004 Standout
Pre-eclampsia
2015 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2018
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Polymorphisms of the β1-adrenergic receptor predict exercise capacity in heart failure
2002
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2010 Standout
Phosphodiesterase 4D is required for β 2 adrenoceptor subtype-specific signaling in cardiac myocytes
2005 StandoutNobel
Contrast-Induced Nephropathy
2006
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
2005
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride
2017
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Preterm labor: One syndrome, many causes
2014 StandoutScience
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Effectiveness of N ‐Acetylcysteine for the Prevention of Contrast‐Induced Nephropathy: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
2016
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
2017
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
2009 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
2010 Standout
What Is the Role of β-Adrenergic Signaling in Heart Failure?
2003
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout

Works of Victor Dishy being referenced

Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis
2015
N-Acetylcysteine ameliorates lithium-induced renal failure in rats
2004
β2-Adrenergic receptor genotype and preterm delivery
2002
ACE inhibitors and survival of hemodialysis patients
2002
Nitric oxide production decreases after salt loading but is not related to blood pressure changes or nitric oxide-mediated vascular responses
2003
The Effect of Common Polymorphisms of the β2-Adrenergic Receptor on Agonist-Mediated Vascular Desensitization
2001
Arg389Gly ??1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo
2001
Serious Consequences to the Use of Cephalosporins as the First Line of Antimicrobial Therapy Administered in Hemodialysis Units
2005
In-vivo effects of Glu298Asp endothelial nitric oxide synthase polymorphism
2001
N-Acetylcysteine Ameliorates Amphotericin-Induced Nephropathy in Rats
2004
The effect of sildenafil on nitric oxide–mediated vasodilation in healthy men
2001
The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiography
2003
The effect of sildenafil on gastric emptying in patients with end-stage renal failure and symptoms of gastroparesis
2004
Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban
2016
G-protein ??3 subunit 825 C/T polymorphism is associated with weight gain during pregnancy
2003
Pharmacokinetics and Pharmacodynamics of MK‐5046, a Bombesin Receptor Subtype‐3 (BRS‐3) Agonist, in Healthy Patients
2011
Edoxaban Effects on Bleeding Following Punch Biopsy and Reversal by a 4-Factor Prothrombin Complex Concentrate
2014
Rankless by CCL
2026